Analyst Price Target is $7.00
▲ +1,804.76% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Aethlon Medical in the last 3 months. The average price target is $7.00, with a high forecast of $7.00 and a low forecast of $7.00. The average price target represents a 1,804.76% upside from the last price of $0.37.
Current Consensus is
Buy
The current consensus among 1 polled investment analysts is to buy stock in Aethlon Medical. This Buy consensus rating has held steady for over two years.
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.
Read More